# Three Fraction Radiation to Induce Immuno-Oncologic Response

> **NCT03978663** · NA · ACTIVE_NOT_RECRUITING · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 40 (estimated)

## Conditions studied

- High-Risk Cancer
- Locally Advanced Breast Cancer

## Interventions

- **RADIATION:** Neoadjuvant radiotherapy

## Key facts

- **NCT ID:** NCT03978663
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-02
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03978663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03978663, "Three Fraction Radiation to Induce Immuno-Oncologic Response". Retrieved via AI Analytics 2026-07-22 from https://api.ai-analytics.org/clinical/NCT03978663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*